• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2015 年至 2020 年世界卫生组织欧洲区域非欧盟成员国梅毒、淋病和衣原体监测和流行病学报告。

Surveillance and epidemiology of syphilis, gonorrhoea and chlamydia in the non-European Union countries of the World Health Organization European Region, 2015 to 2020.

机构信息

World Health Organization Collaborating Centre for HIV Strategic Information, University of Zagreb School of Medicine, Zagreb, Croatia.

World Health Organization Regional Office for Europe, Copenhagen, Denmark.

出版信息

Euro Surveill. 2022 Feb;27(8). doi: 10.2807/1560-7917.ES.2022.27.8.2100197.

DOI:10.2807/1560-7917.ES.2022.27.8.2100197
PMID:35209970
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8874864/
Abstract

BackgroundEpidemics of sexually transmitted infections (STI) are a major public health challenge in the World Health Organization (WHO) European Region.AimWe aimed to provide an overview of case reporting and other surveillance data for syphilis, gonorrhoea and chlamydia for the non-European Union (EU)/European Economic Area (EEA) countries of the Centre and East part of the WHO European Region as per classification used by the WHO Regional Office for Europe (WHO/Europe) and the European Centre for Disease Prevention and Control.MethodsData were provided by the surveillance agencies of the Member States for the period 2015 to 2019 through the WHO/Europe Communicable Diseases Annual Reporting Form. We analysed reported cases, explored data reported to the WHO Gonococcal Antimicrobial Surveillance Programme (GASP) and performed a review of publications on antimicrobial resistance (AMR) in gonorrhoea in the period 2015 to 2020 using systematic methodology.ResultsFrom 2015 to 2019, in most of the countries with three or more data points, there was a pattern of decrease in reported syphilis, gonorrhoea and chlamydia cases, which is in contrast to the EU/EEA. The number of reported cases per 100,000 population was 0.4-26.5 for syphilis, 0-18.5 for gonorrhoea and 0-43.3 for chlamydia. Four countries reported recent data on AMR in gonorrhoea to GASP, and we identified further publications from Georgia, Russia and Ukraine.ConclusionWe found wide heterogeneity in reported rates of STI. There is a strong need to improve availability and quality of STI surveillance data in the non-EU/EEA countries.

摘要

背景

性传播感染(STI)的流行是世界卫生组织(WHO)欧洲区域面临的主要公共卫生挑战。

目的

按照世界卫生组织欧洲区域办事处(WHO/Europe)和欧洲疾病预防控制中心使用的分类,对 WHO 欧洲区域中部和东部非欧盟/欧洲经济区(EU/EEA)国家的梅毒、淋病和衣原体病例报告和其他监测数据进行概述。

方法

成员国的监测机构通过 WHO/Europe 传染病年度报告表,在 2015 年至 2019 年期间提供了数据。我们分析了报告病例,探讨了向 WHO 淋球菌抗菌药物监测计划(GASP)报告的数据,并使用系统方法审查了 2015 年至 2020 年期间淋病抗微生物药物耐药性(AMR)的出版物。

结果

在大多数有三个或更多数据点的国家,2015 年至 2019 年期间报告的梅毒、淋病和衣原体病例呈下降趋势,这与欧盟/EEA 形成了对比。每 10 万人口报告的病例数为梅毒 0.4-26.5、淋病 0-18.5、衣原体 0-43.3。四个国家向 GASP 报告了最近的淋病 AMR 数据,我们还从格鲁吉亚、俄罗斯和乌克兰确定了其他出版物。

结论

我们发现报告的 STI 率存在很大差异。非常有必要改善非欧盟/EEA 国家 STI 监测数据的可获得性和质量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25cb/8874864/13b3ec1b4aa9/2100197-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25cb/8874864/13b3ec1b4aa9/2100197-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25cb/8874864/13b3ec1b4aa9/2100197-f1.jpg

相似文献

1
Surveillance and epidemiology of syphilis, gonorrhoea and chlamydia in the non-European Union countries of the World Health Organization European Region, 2015 to 2020.2015 年至 2020 年世界卫生组织欧洲区域非欧盟成员国梅毒、淋病和衣原体监测和流行病学报告。
Euro Surveill. 2022 Feb;27(8). doi: 10.2807/1560-7917.ES.2022.27.8.2100197.
2
Sexually transmitted infections in the non-European Union and European Economic Area of the World Health Organization European Region 2021-2023.世界卫生组织欧洲区域非欧盟和欧洲经济区2021 - 2023年性传播感染情况
BMC Public Health. 2025 Apr 25;25(1):1545. doi: 10.1186/s12889-025-22630-6.
3
Likelihood of HIV and recent bacterial sexually transmitted infections among transgender and non-binary individuals in 20 European countries, October 2023 to April 2024.2023 年 10 月至 2024 年 4 月,20 个欧洲国家跨性别和非二进制个体中 HIV 和近期细菌性性传播感染的可能性。
Euro Surveill. 2024 Nov;29(48). doi: 10.2807/1560-7917.ES.2024.29.48.2400347.
4
Gonorrhoea and gonococcal antimicrobial resistance surveillance networks in the WHO European Region, including the independent countries of the former Soviet Union.世界卫生组织欧洲区域淋病和淋球菌抗菌药物耐药性监测网络,包括前苏联各独立国家。
Sex Transm Infect. 2013 Dec;89 Suppl 4:iv42-6. doi: 10.1136/sextrans-2012-050909.
5
The European gonococcal antimicrobial surveillance programme (Euro-GASP) appropriately reflects the antimicrobial resistance situation for Neisseria gonorrhoeae in the European Union/European Economic Area.欧洲淋球菌抗菌药物监测计划(Euro-GASP)恰当地反映了欧盟/欧洲经济区淋病奈瑟菌的抗菌药物耐药情况。
BMC Infect Dis. 2019 Dec 10;19(1):1040. doi: 10.1186/s12879-019-4631-x.
6
Risk for HIV following a diagnosis of syphilis, gonorrhoea or chlamydia: 328,456 women in Florida, 2000-2011.梅毒、淋病或衣原体感染诊断后感染艾滋病毒的风险:2000年至2011年佛罗里达州的328,456名女性。
Int J STD AIDS. 2015 Feb;26(2):113-9. doi: 10.1177/0956462414531243. Epub 2014 Apr 8.
7
Antimicrobial resistance in isolates from foreign-born population in the European Gonococcal Antimicrobial Surveillance Programme.欧洲淋球菌抗菌药物监测计划中来自外国出生人群的 分离株的抗菌药物耐药性。
Sex Transm Infect. 2020 May;96(3):204-210. doi: 10.1136/sextrans-2018-053912. Epub 2020 Feb 4.
8
The European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP)--a sentinel approach in the European Union (EU)/European Economic Area (EEA).欧洲淋球菌抗菌药物监测项目(Euro-GASP)——欧盟/欧洲经济区(EEA)的一种哨点监测方法。
Sex Transm Infect. 2013 Dec;89 Suppl 4:iv16-8. doi: 10.1136/sextrans-2013-051117.
9
Sexually transmitted infections in Poland in 2013-2018 in comparison to other European countries based on infectious diseases surveillance in Poland and in Europe.2013-2018 年波兰与其他欧洲国家性传播感染的比较:基于波兰和欧洲传染病监测。
Przegl Epidemiol. 2021;75(4):502-514. doi: 10.32394/pe.75.47.
10
Gonorrhoea, chlamydia and syphilis incidence in the Kimberley.金伯利地区淋病、衣原体感染和梅毒的发病率。
Commun Dis Intell Q Rep. 2003;27(3):370-2.

引用本文的文献

1
Sexually transmitted infections in the non-European Union and European Economic Area of the World Health Organization European Region 2021-2023.世界卫生组织欧洲区域非欧盟和欧洲经济区2021 - 2023年性传播感染情况
BMC Public Health. 2025 Apr 25;25(1):1545. doi: 10.1186/s12889-025-22630-6.
2
Remarkable spine erosion in cardiovascular syphilis - Computed tomography reconstruction of a century-old forensic case.心血管梅毒中显著的脊柱侵蚀——一个百年法医病例的计算机断层扫描重建
Forensic Sci Med Pathol. 2025 Feb 17. doi: 10.1007/s12024-025-00961-5.
3
Neurosyphilis-Induced Psychosis in Europe: A Systematic Review of Case Reports.

本文引用的文献

1
COVID-19, HIV and key populations: cross-cutting issues and the need for population-specific responses.COVID-19、HIV 和重点人群:交叉问题和针对特定人群的应对需求。
J Int AIDS Soc. 2020 Oct;23(10):e25632. doi: 10.1002/jia2.25632.
2
Herpes simplex virus: global infection prevalence and incidence estimates, 2016.单纯疱疹病毒:2016 年全球感染流行率和发病率估计。
Bull World Health Organ. 2020 May 1;98(5):315-329. doi: 10.2471/BLT.19.237149. Epub 2020 Mar 25.
3
Genomic epidemiology and antimicrobial resistance determinants of Neisseria gonorrhoeae isolates from Ukraine, 2013-2018.
欧洲神经梅毒所致精神病:病例报告的系统评价
Pathogens. 2024 Nov 4;13(11):959. doi: 10.3390/pathogens13110959.
4
Assessing the Quality and Accuracy of Syphilis-Related Content on TikTok and YouTube: A Comprehensive Analysis.评估TikTok和YouTube上梅毒相关内容的质量与准确性:一项综合分析。
Sex Transm Dis. 2025 Feb 1;52(2):81-86. doi: 10.1097/OLQ.0000000000002090. Epub 2024 Oct 29.
5
Syphilitic hepatitis.梅毒性肝炎
Clin Exp Hepatol. 2024 Mar;10(1):9-13. doi: 10.5114/ceh.2024.136235. Epub 2024 Mar 12.
6
Epidemiology and determinants of reemerging bacterial sexually transmitted infections (STIs) and emerging STIs in Europe.欧洲再度出现的细菌性性传播感染(STIs)和新出现的性传播感染的流行病学及决定因素。
Lancet Reg Health Eur. 2023 Oct 26;34:100742. doi: 10.1016/j.lanepe.2023.100742. eCollection 2023 Nov.
7
Knowledge about and prevalence of Chlamydia trachomatis in a population-based sample of emerging Croatian adults.基于人群的克罗地亚新兴成年人样本中沙眼衣原体的知识和流行情况。
PLoS One. 2023 Oct 27;18(10):e0293224. doi: 10.1371/journal.pone.0293224. eCollection 2023.
8
Machine learning models for Neisseria gonorrhoeae antimicrobial susceptibility tests.淋病奈瑟菌抗菌药物敏感性试验的机器学习模型。
Ann N Y Acad Sci. 2023 Feb;1520(1):74-88. doi: 10.1111/nyas.14549. Epub 2022 Dec 27.
2013-2018 年乌克兰淋病奈瑟菌分离株的基因组流行病学和抗菌药物耐药决定因素。
APMIS. 2020 Jul;128(7):465-475. doi: 10.1111/apm.13060.
4
Rapid inference of antibiotic resistance and susceptibility by genomic neighbour typing.基于基因组邻近分型的抗生素耐药性和药敏性快速推断。
Nat Microbiol. 2020 Mar;5(3):455-464. doi: 10.1038/s41564-019-0656-6. Epub 2020 Feb 10.
5
Antimicrobial resistance in isolates from foreign-born population in the European Gonococcal Antimicrobial Surveillance Programme.欧洲淋球菌抗菌药物监测计划中来自外国出生人群的 分离株的抗菌药物耐药性。
Sex Transm Infect. 2020 May;96(3):204-210. doi: 10.1136/sextrans-2018-053912. Epub 2020 Feb 4.
6
Genetic diversity of Neisseria gonorrhoeae multi-antigen sequence types in Russia and Europe.淋病奈瑟菌多抗原序列型在俄罗斯和欧洲的遗传多样性。
Int J Infect Dis. 2020 Apr;93:1-8. doi: 10.1016/j.ijid.2020.01.020. Epub 2020 Jan 21.
7
World Health Organization Global Gonococcal Antimicrobial Surveillance Program (WHO GASP): review of new data and evidence to inform international collaborative actions and research efforts.世界卫生组织全球淋球菌抗菌监测项目(WHO GASP):对新数据和证据的综述,以为国际合作行动和研究工作提供信息
Sex Health. 2019 Sep;16(5):412-425. doi: 10.1071/SH19023.
8
Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016.淋病、衣原体、滴虫病和梅毒:2016 年全球流行率和发病率估计值。
Bull World Health Organ. 2019 Aug 1;97(8):548-562P. doi: 10.2471/BLT.18.228486. Epub 2019 Jun 6.
9
Resistance of Neisseria gonorrhoeae isolates to beta-lactam antibiotics (benzylpenicillin and ceftriaxone) in Russia, 2015-2017.2015-2017 年俄罗斯淋病奈瑟菌分离株对β-内酰胺类抗生素(青霉素和头孢曲松)的耐药性。
PLoS One. 2019 Jul 25;14(7):e0220339. doi: 10.1371/journal.pone.0220339. eCollection 2019.
10
High prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae and particularly Trichomonas vaginalis diagnosed using US FDA-approved Aptima molecular tests and evaluation of conventional routine diagnostic tests in Ternopil, Ukraine.在乌克兰特尔诺皮尔,使用美国食品和药物管理局批准的 Aptima 分子检测方法诊断出沙眼衣原体、淋病奈瑟菌的高流行率,特别是阴道毛滴虫。同时评估了常规常规诊断检测。
APMIS. 2019 Sep;127(9):627-634. doi: 10.1111/apm.12975.